|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 47/18 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1478339 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03709188.1 |
| Date of filing the European patent application | 2003-02-20 | |
| (97) | Date of publication of the European application | 2004-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2008-06-04 |
| (46) | Date of publication of the claims translation | 2008-09-25 |
| (86) | Number | PCT/US2003/005018 |
| Date | 2003-02-20 |
| (87) | Number | WO 2003/072082 |
| Date | 2003-09-04 |
| (30) | Number | Date | Country code |
| 359198 P | 2002-02-22 | US |
| (72) |
UGWU, Sydney, US
RADHAKRISHNAN, Vinay, US
IHNAT, Peter, M., US
WITCHEY-LAKSHMANAN, Leonore, C., US
|
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Antineoplastinių agentų, ypač temozolomido, farmaciniai preparatai, jų gamybos būdai ir panaudojimas |
| PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS, IN PARTICULAR TEMOZOLOMIDE, PROCESSES OF MAKING AND USING THE SAME |
| Payment date | Validity (years) | Amount | |
| 2022-02-03 | 347.00 EUR |